nodes	percent_of_prediction	percent_of_DWPC	metapath
Cefoxitin—Vulvovaginal mycotic infection—Progesterone—uterine cancer	0.0243	0.0243	CcSEcCtD
Cefoxitin—Vaginal moniliasis—Medroxyprogesterone Acetate—uterine cancer	0.0238	0.0238	CcSEcCtD
Cefoxitin—Vulvovaginal candidiasis—Medroxyprogesterone Acetate—uterine cancer	0.0229	0.0229	CcSEcCtD
Cefoxitin—Vulvovaginal mycotic infection—Medroxyprogesterone Acetate—uterine cancer	0.022	0.022	CcSEcCtD
Cefoxitin—Phlebitis—Carboplatin—uterine cancer	0.0213	0.0213	CcSEcCtD
Cefoxitin—Nephritis interstitial—Medroxyprogesterone Acetate—uterine cancer	0.0178	0.0178	CcSEcCtD
Cefoxitin—Cholestasis—Progesterone—uterine cancer	0.0175	0.0175	CcSEcCtD
Cefoxitin—Tubulointerstitial nephritis—Medroxyprogesterone Acetate—uterine cancer	0.0157	0.0157	CcSEcCtD
Cefoxitin—Tenderness—Progesterone—uterine cancer	0.0152	0.0152	CcSEcCtD
Cefoxitin—Induration—Etoposide—uterine cancer	0.0152	0.0152	CcSEcCtD
Cefoxitin—Tenderness—Medroxyprogesterone Acetate—uterine cancer	0.0138	0.0138	CcSEcCtD
Cefoxitin—Vaginal inflammation—Progesterone—uterine cancer	0.0133	0.0133	CcSEcCtD
Cefoxitin—Vaginal infection—Progesterone—uterine cancer	0.0125	0.0125	CcSEcCtD
Cefoxitin—Vaginal inflammation—Medroxyprogesterone Acetate—uterine cancer	0.012	0.012	CcSEcCtD
Cefoxitin—Nephropathy toxic—Etoposide—uterine cancer	0.0118	0.0118	CcSEcCtD
Cefoxitin—Vaginal infection—Medroxyprogesterone Acetate—uterine cancer	0.0114	0.0114	CcSEcCtD
Cefoxitin—Thrombophlebitis—Progesterone—uterine cancer	0.0111	0.0111	CcSEcCtD
Cefoxitin—Hepatic function abnormal—Progesterone—uterine cancer	0.011	0.011	CcSEcCtD
Cefoxitin—Thrombophlebitis—Medroxyprogesterone Acetate—uterine cancer	0.0101	0.0101	CcSEcCtD
Cefoxitin—Hepatic function abnormal—Medroxyprogesterone Acetate—uterine cancer	0.00999	0.00999	CcSEcCtD
Cefoxitin—Haemolytic anaemia—Medroxyprogesterone Acetate—uterine cancer	0.00967	0.00967	CcSEcCtD
Cefoxitin—Prothrombin level increased—Epirubicin—uterine cancer	0.00927	0.00927	CcSEcCtD
Cefoxitin—Aplastic anaemia—Dactinomycin—uterine cancer	0.00881	0.00881	CcSEcCtD
Cefoxitin—Prothrombin level increased—Doxorubicin—uterine cancer	0.00858	0.00858	CcSEcCtD
Cefoxitin—Phlebitis—Dactinomycin—uterine cancer	0.0079	0.0079	CcSEcCtD
Cefoxitin—Pain—Carboplatin—uterine cancer	0.00771	0.00771	CcSEcCtD
Cefoxitin—Vaginal moniliasis—Epirubicin—uterine cancer	0.00754	0.00754	CcSEcCtD
Cefoxitin—Vulvovaginal candidiasis—Epirubicin—uterine cancer	0.00724	0.00724	CcSEcCtD
Cefoxitin—Jaundice—Progesterone—uterine cancer	0.00724	0.00724	CcSEcCtD
Cefoxitin—Body temperature increased—Carboplatin—uterine cancer	0.00712	0.00712	CcSEcCtD
Cefoxitin—Vaginal moniliasis—Doxorubicin—uterine cancer	0.00698	0.00698	CcSEcCtD
Cefoxitin—Vulvovaginal mycotic infection—Epirubicin—uterine cancer	0.00696	0.00696	CcSEcCtD
Cefoxitin—Local reaction—Epirubicin—uterine cancer	0.00687	0.00687	CcSEcCtD
Cefoxitin—Haemoglobin—Progesterone—uterine cancer	0.0067	0.0067	CcSEcCtD
Cefoxitin—Vulvovaginal candidiasis—Doxorubicin—uterine cancer	0.0067	0.0067	CcSEcCtD
Cefoxitin—Haemorrhage—Progesterone—uterine cancer	0.00666	0.00666	CcSEcCtD
Cefoxitin—Urinary tract disorder—Progesterone—uterine cancer	0.00658	0.00658	CcSEcCtD
Cefoxitin—Jaundice—Medroxyprogesterone Acetate—uterine cancer	0.00656	0.00656	CcSEcCtD
Cefoxitin—Urethral disorder—Progesterone—uterine cancer	0.00653	0.00653	CcSEcCtD
Cefoxitin—Candida infection—Etoposide—uterine cancer	0.00648	0.00648	CcSEcCtD
Cefoxitin—Vulvovaginal mycotic infection—Doxorubicin—uterine cancer	0.00644	0.00644	CcSEcCtD
Cefoxitin—Local reaction—Doxorubicin—uterine cancer	0.00636	0.00636	CcSEcCtD
Cefoxitin—Erythema multiforme—Progesterone—uterine cancer	0.0063	0.0063	CcSEcCtD
Cefoxitin—Rash maculo-papular—Etoposide—uterine cancer	0.00617	0.00617	CcSEcCtD
Cefoxitin—Toxic epidermal necrolysis—Dactinomycin—uterine cancer	0.00613	0.00613	CcSEcCtD
Cefoxitin—Haemoglobin—Medroxyprogesterone Acetate—uterine cancer	0.00607	0.00607	CcSEcCtD
Cefoxitin—Haemorrhage—Medroxyprogesterone Acetate—uterine cancer	0.00604	0.00604	CcSEcCtD
Cefoxitin—Urinary tract disorder—Medroxyprogesterone Acetate—uterine cancer	0.00596	0.00596	CcSEcCtD
Cefoxitin—Urethral disorder—Medroxyprogesterone Acetate—uterine cancer	0.00592	0.00592	CcSEcCtD
Cefoxitin—Erythema—Progesterone—uterine cancer	0.0058	0.0058	CcSEcCtD
Cefoxitin—Phlebitis—Etoposide—uterine cancer	0.00572	0.00572	CcSEcCtD
Cefoxitin—Erythema multiforme—Medroxyprogesterone Acetate—uterine cancer	0.00571	0.00571	CcSEcCtD
Cefoxitin—Bone marrow depression—Epirubicin—uterine cancer	0.00564	0.00564	CcSEcCtD
Cefoxitin—Pancytopenia—Dactinomycin—uterine cancer	0.00559	0.00559	CcSEcCtD
Cefoxitin—Neutropenia—Dactinomycin—uterine cancer	0.0055	0.0055	CcSEcCtD
Cefoxitin—Anaemia—Progesterone—uterine cancer	0.00536	0.00536	CcSEcCtD
Cefoxitin—Angioedema—Progesterone—uterine cancer	0.0053	0.0053	CcSEcCtD
Cefoxitin—Erythema—Medroxyprogesterone Acetate—uterine cancer	0.00526	0.00526	CcSEcCtD
Cefoxitin—Bone marrow depression—Doxorubicin—uterine cancer	0.00522	0.00522	CcSEcCtD
Cefoxitin—Stevens-Johnson syndrome—Dactinomycin—uterine cancer	0.0052	0.0052	CcSEcCtD
Cefoxitin—Convulsion—Progesterone—uterine cancer	0.00503	0.00503	CcSEcCtD
Cefoxitin—Agranulocytosis—Dactinomycin—uterine cancer	0.0049	0.0049	CcSEcCtD
Cefoxitin—Anaemia—Medroxyprogesterone Acetate—uterine cancer	0.00486	0.00486	CcSEcCtD
Cefoxitin—Angioedema—Medroxyprogesterone Acetate—uterine cancer	0.0048	0.0048	CcSEcCtD
Cefoxitin—Anaphylactic shock—Progesterone—uterine cancer	0.00473	0.00473	CcSEcCtD
Cefoxitin—Convulsion—Medroxyprogesterone Acetate—uterine cancer	0.00455	0.00455	CcSEcCtD
Cefoxitin—Erythema multiforme—Dactinomycin—uterine cancer	0.00445	0.00445	CcSEcCtD
Cefoxitin—Toxic epidermal necrolysis—Etoposide—uterine cancer	0.00444	0.00444	CcSEcCtD
Cefoxitin—Hypotension—Progesterone—uterine cancer	0.00442	0.00442	CcSEcCtD
Cefoxitin—Flushing—Dactinomycin—uterine cancer	0.00437	0.00437	CcSEcCtD
Cefoxitin—Anaphylactic shock—Medroxyprogesterone Acetate—uterine cancer	0.00429	0.00429	CcSEcCtD
Cefoxitin—Dyspnoea—Progesterone—uterine cancer	0.00422	0.00422	CcSEcCtD
Cefoxitin—Thrombocytopenia—Medroxyprogesterone Acetate—uterine cancer	0.0042	0.0042	CcSEcCtD
Cefoxitin—Erythema—Dactinomycin—uterine cancer	0.0041	0.0041	CcSEcCtD
Cefoxitin—Pain—Progesterone—uterine cancer	0.00405	0.00405	CcSEcCtD
Cefoxitin—Pancytopenia—Etoposide—uterine cancer	0.00404	0.00404	CcSEcCtD
Cefoxitin—Blood bilirubin increased—Epirubicin—uterine cancer	0.00402	0.00402	CcSEcCtD
Cefoxitin—Hypotension—Medroxyprogesterone Acetate—uterine cancer	0.00401	0.00401	CcSEcCtD
Cefoxitin—Neutropenia—Etoposide—uterine cancer	0.00398	0.00398	CcSEcCtD
Cefoxitin—Gastrointestinal pain—Progesterone—uterine cancer	0.00387	0.00387	CcSEcCtD
Cefoxitin—Dyspnoea—Medroxyprogesterone Acetate—uterine cancer	0.00382	0.00382	CcSEcCtD
Cefoxitin—Vaginal inflammation—Epirubicin—uterine cancer	0.00381	0.00381	CcSEcCtD
Cefoxitin—Anaemia—Dactinomycin—uterine cancer	0.00379	0.00379	CcSEcCtD
Cefoxitin—Stevens-Johnson syndrome—Etoposide—uterine cancer	0.00376	0.00376	CcSEcCtD
Cefoxitin—Urticaria—Progesterone—uterine cancer	0.00376	0.00376	CcSEcCtD
Cefoxitin—Abdominal pain—Progesterone—uterine cancer	0.00374	0.00374	CcSEcCtD
Cefoxitin—Body temperature increased—Progesterone—uterine cancer	0.00374	0.00374	CcSEcCtD
Cefoxitin—Blood bilirubin increased—Doxorubicin—uterine cancer	0.00372	0.00372	CcSEcCtD
Cefoxitin—Jaundice—Etoposide—uterine cancer	0.0037	0.0037	CcSEcCtD
Cefoxitin—Leukopenia—Dactinomycin—uterine cancer	0.00367	0.00367	CcSEcCtD
Cefoxitin—Colitis—Epirubicin—uterine cancer	0.00365	0.00365	CcSEcCtD
Cefoxitin—Candida infection—Epirubicin—uterine cancer	0.00363	0.00363	CcSEcCtD
Cefoxitin—Vaginal infection—Epirubicin—uterine cancer	0.00359	0.00359	CcSEcCtD
Cefoxitin—Aplastic anaemia—Epirubicin—uterine cancer	0.00357	0.00357	CcSEcCtD
Cefoxitin—Agranulocytosis—Etoposide—uterine cancer	0.00354	0.00354	CcSEcCtD
Cefoxitin—Vaginal inflammation—Doxorubicin—uterine cancer	0.00352	0.00352	CcSEcCtD
Cefoxitin—Gastrointestinal pain—Medroxyprogesterone Acetate—uterine cancer	0.00351	0.00351	CcSEcCtD
Cefoxitin—Hypersensitivity—Progesterone—uterine cancer	0.00349	0.00349	CcSEcCtD
Cefoxitin—Rash maculo-papular—Epirubicin—uterine cancer	0.00346	0.00346	CcSEcCtD
Cefoxitin—Urticaria—Medroxyprogesterone Acetate—uterine cancer	0.00341	0.00341	CcSEcCtD
Cefoxitin—Abdominal pain—Medroxyprogesterone Acetate—uterine cancer	0.00339	0.00339	CcSEcCtD
Cefoxitin—Body temperature increased—Medroxyprogesterone Acetate—uterine cancer	0.00339	0.00339	CcSEcCtD
Cefoxitin—Colitis—Doxorubicin—uterine cancer	0.00338	0.00338	CcSEcCtD
Cefoxitin—Urinary tract disorder—Etoposide—uterine cancer	0.00337	0.00337	CcSEcCtD
Cefoxitin—Candida infection—Doxorubicin—uterine cancer	0.00336	0.00336	CcSEcCtD
Cefoxitin—Pruritus—Progesterone—uterine cancer	0.00335	0.00335	CcSEcCtD
Cefoxitin—Urethral disorder—Etoposide—uterine cancer	0.00334	0.00334	CcSEcCtD
Cefoxitin—Vaginal infection—Doxorubicin—uterine cancer	0.00332	0.00332	CcSEcCtD
Cefoxitin—Aplastic anaemia—Doxorubicin—uterine cancer	0.00331	0.00331	CcSEcCtD
Cefoxitin—Thrombocytopenia—Dactinomycin—uterine cancer	0.00328	0.00328	CcSEcCtD
Cefoxitin—Diarrhoea—Progesterone—uterine cancer	0.00324	0.00324	CcSEcCtD
Cefoxitin—Erythema multiforme—Etoposide—uterine cancer	0.00322	0.00322	CcSEcCtD
Cefoxitin—Phlebitis—Epirubicin—uterine cancer	0.00321	0.00321	CcSEcCtD
Cefoxitin—Rash maculo-papular—Doxorubicin—uterine cancer	0.0032	0.0032	CcSEcCtD
Cefoxitin—Thrombophlebitis—Epirubicin—uterine cancer	0.00319	0.00319	CcSEcCtD
Cefoxitin—Flushing—Etoposide—uterine cancer	0.00316	0.00316	CcSEcCtD
Cefoxitin—Hypersensitivity—Medroxyprogesterone Acetate—uterine cancer	0.00316	0.00316	CcSEcCtD
Cefoxitin—Hepatic function abnormal—Epirubicin—uterine cancer	0.00316	0.00316	CcSEcCtD
Cefoxitin—Pruritus—Medroxyprogesterone Acetate—uterine cancer	0.00304	0.00304	CcSEcCtD
Cefoxitin—Vomiting—Progesterone—uterine cancer	0.00301	0.00301	CcSEcCtD
Cefoxitin—Renal failure acute—Epirubicin—uterine cancer	0.00299	0.00299	CcSEcCtD
Cefoxitin—Rash—Progesterone—uterine cancer	0.00299	0.00299	CcSEcCtD
Cefoxitin—Dermatitis—Progesterone—uterine cancer	0.00298	0.00298	CcSEcCtD
Cefoxitin—Phlebitis—Doxorubicin—uterine cancer	0.00297	0.00297	CcSEcCtD
Cefoxitin—Thrombophlebitis—Doxorubicin—uterine cancer	0.00295	0.00295	CcSEcCtD
Cefoxitin—Diarrhoea—Medroxyprogesterone Acetate—uterine cancer	0.00294	0.00294	CcSEcCtD
Cefoxitin—Dermatitis exfoliative—Epirubicin—uterine cancer	0.00293	0.00293	CcSEcCtD
Cefoxitin—Hepatic function abnormal—Doxorubicin—uterine cancer	0.00292	0.00292	CcSEcCtD
Cefoxitin—Pain—Dactinomycin—uterine cancer	0.00286	0.00286	CcSEcCtD
Cefoxitin—Nausea—Progesterone—uterine cancer	0.00281	0.00281	CcSEcCtD
Cefoxitin—Renal failure acute—Doxorubicin—uterine cancer	0.00277	0.00277	CcSEcCtD
Cefoxitin—Anaemia—Etoposide—uterine cancer	0.00274	0.00274	CcSEcCtD
Cefoxitin—Gastrointestinal pain—Dactinomycin—uterine cancer	0.00274	0.00274	CcSEcCtD
Cefoxitin—Vomiting—Medroxyprogesterone Acetate—uterine cancer	0.00273	0.00273	CcSEcCtD
Cefoxitin—Dermatitis exfoliative—Doxorubicin—uterine cancer	0.00271	0.00271	CcSEcCtD
Cefoxitin—Rash—Medroxyprogesterone Acetate—uterine cancer	0.0027	0.0027	CcSEcCtD
Cefoxitin—Dermatitis—Medroxyprogesterone Acetate—uterine cancer	0.0027	0.0027	CcSEcCtD
Cefoxitin—Leukopenia—Etoposide—uterine cancer	0.00266	0.00266	CcSEcCtD
Cefoxitin—Body temperature increased—Dactinomycin—uterine cancer	0.00265	0.00265	CcSEcCtD
Cefoxitin—Abdominal pain—Dactinomycin—uterine cancer	0.00265	0.00265	CcSEcCtD
Cefoxitin—Convulsion—Etoposide—uterine cancer	0.00257	0.00257	CcSEcCtD
Cefoxitin—Nausea—Medroxyprogesterone Acetate—uterine cancer	0.00255	0.00255	CcSEcCtD
Cefoxitin—Toxic epidermal necrolysis—Epirubicin—uterine cancer	0.00249	0.00249	CcSEcCtD
Cefoxitin—Hypersensitivity—Dactinomycin—uterine cancer	0.00247	0.00247	CcSEcCtD
Cefoxitin—Anaphylactic shock—Etoposide—uterine cancer	0.00242	0.00242	CcSEcCtD
Cefoxitin—Thrombocytopenia—Etoposide—uterine cancer	0.00237	0.00237	CcSEcCtD
Cefoxitin—Eosinophilia—Epirubicin—uterine cancer	0.00236	0.00236	CcSEcCtD
Cefoxitin—Toxic epidermal necrolysis—Doxorubicin—uterine cancer	0.0023	0.0023	CcSEcCtD
Cefoxitin—Diarrhoea—Dactinomycin—uterine cancer	0.00229	0.00229	CcSEcCtD
Cefoxitin—Pancytopenia—Epirubicin—uterine cancer	0.00227	0.00227	CcSEcCtD
Cefoxitin—Hypotension—Etoposide—uterine cancer	0.00226	0.00226	CcSEcCtD
Cefoxitin—Neutropenia—Epirubicin—uterine cancer	0.00223	0.00223	CcSEcCtD
Cefoxitin—Eosinophilia—Doxorubicin—uterine cancer	0.00219	0.00219	CcSEcCtD
Cefoxitin—Dyspnoea—Etoposide—uterine cancer	0.00216	0.00216	CcSEcCtD
Cefoxitin—Vomiting—Dactinomycin—uterine cancer	0.00213	0.00213	CcSEcCtD
Cefoxitin—Stevens-Johnson syndrome—Epirubicin—uterine cancer	0.00211	0.00211	CcSEcCtD
Cefoxitin—Rash—Dactinomycin—uterine cancer	0.00211	0.00211	CcSEcCtD
Cefoxitin—Pancytopenia—Doxorubicin—uterine cancer	0.0021	0.0021	CcSEcCtD
Cefoxitin—Jaundice—Epirubicin—uterine cancer	0.00207	0.00207	CcSEcCtD
Cefoxitin—Pain—Etoposide—uterine cancer	0.00207	0.00207	CcSEcCtD
Cefoxitin—Neutropenia—Doxorubicin—uterine cancer	0.00207	0.00207	CcSEcCtD
Cefoxitin—Nausea—Dactinomycin—uterine cancer	0.00199	0.00199	CcSEcCtD
Cefoxitin—Agranulocytosis—Epirubicin—uterine cancer	0.00199	0.00199	CcSEcCtD
Cefoxitin—Gastrointestinal pain—Etoposide—uterine cancer	0.00198	0.00198	CcSEcCtD
Cefoxitin—Stevens-Johnson syndrome—Doxorubicin—uterine cancer	0.00195	0.00195	CcSEcCtD
Cefoxitin—Urticaria—Etoposide—uterine cancer	0.00192	0.00192	CcSEcCtD
Cefoxitin—Haemoglobin—Epirubicin—uterine cancer	0.00192	0.00192	CcSEcCtD
Cefoxitin—Jaundice—Doxorubicin—uterine cancer	0.00192	0.00192	CcSEcCtD
Cefoxitin—Abdominal pain—Etoposide—uterine cancer	0.00191	0.00191	CcSEcCtD
Cefoxitin—Body temperature increased—Etoposide—uterine cancer	0.00191	0.00191	CcSEcCtD
Cefoxitin—Haemorrhage—Epirubicin—uterine cancer	0.00191	0.00191	CcSEcCtD
Cefoxitin—Urinary tract disorder—Epirubicin—uterine cancer	0.00189	0.00189	CcSEcCtD
Cefoxitin—Urethral disorder—Epirubicin—uterine cancer	0.00187	0.00187	CcSEcCtD
Cefoxitin—Agranulocytosis—Doxorubicin—uterine cancer	0.00184	0.00184	CcSEcCtD
Cefoxitin—Erythema multiforme—Epirubicin—uterine cancer	0.00181	0.00181	CcSEcCtD
Cefoxitin—Hypersensitivity—Etoposide—uterine cancer	0.00178	0.00178	CcSEcCtD
Cefoxitin—Haemoglobin—Doxorubicin—uterine cancer	0.00178	0.00178	CcSEcCtD
Cefoxitin—Flushing—Epirubicin—uterine cancer	0.00177	0.00177	CcSEcCtD
Cefoxitin—Haemorrhage—Doxorubicin—uterine cancer	0.00177	0.00177	CcSEcCtD
Cefoxitin—Urinary tract disorder—Doxorubicin—uterine cancer	0.00175	0.00175	CcSEcCtD
Cefoxitin—Urethral disorder—Doxorubicin—uterine cancer	0.00173	0.00173	CcSEcCtD
Cefoxitin—Pruritus—Etoposide—uterine cancer	0.00171	0.00171	CcSEcCtD
Cefoxitin—Erythema multiforme—Doxorubicin—uterine cancer	0.00167	0.00167	CcSEcCtD
Cefoxitin—Erythema—Epirubicin—uterine cancer	0.00166	0.00166	CcSEcCtD
Cefoxitin—Diarrhoea—Etoposide—uterine cancer	0.00166	0.00166	CcSEcCtD
Cefoxitin—Flushing—Doxorubicin—uterine cancer	0.00164	0.00164	CcSEcCtD
Cefoxitin—Vomiting—Etoposide—uterine cancer	0.00154	0.00154	CcSEcCtD
Cefoxitin—Erythema—Doxorubicin—uterine cancer	0.00154	0.00154	CcSEcCtD
Cefoxitin—Anaemia—Epirubicin—uterine cancer	0.00154	0.00154	CcSEcCtD
Cefoxitin—Rash—Etoposide—uterine cancer	0.00153	0.00153	CcSEcCtD
Cefoxitin—Dermatitis—Etoposide—uterine cancer	0.00153	0.00153	CcSEcCtD
Cefoxitin—Leukopenia—Epirubicin—uterine cancer	0.00149	0.00149	CcSEcCtD
Cefoxitin—Convulsion—Epirubicin—uterine cancer	0.00144	0.00144	CcSEcCtD
Cefoxitin—Nausea—Etoposide—uterine cancer	0.00144	0.00144	CcSEcCtD
Cefoxitin—Anaemia—Doxorubicin—uterine cancer	0.00142	0.00142	CcSEcCtD
Cefoxitin—Leukopenia—Doxorubicin—uterine cancer	0.00138	0.00138	CcSEcCtD
Cefoxitin—Anaphylactic shock—Epirubicin—uterine cancer	0.00136	0.00136	CcSEcCtD
Cefoxitin—Convulsion—Doxorubicin—uterine cancer	0.00133	0.00133	CcSEcCtD
Cefoxitin—Thrombocytopenia—Epirubicin—uterine cancer	0.00133	0.00133	CcSEcCtD
Cefoxitin—Hypotension—Epirubicin—uterine cancer	0.00127	0.00127	CcSEcCtD
Cefoxitin—Anaphylactic shock—Doxorubicin—uterine cancer	0.00126	0.00126	CcSEcCtD
Cefoxitin—Thrombocytopenia—Doxorubicin—uterine cancer	0.00123	0.00123	CcSEcCtD
Cefoxitin—Dyspnoea—Epirubicin—uterine cancer	0.00121	0.00121	CcSEcCtD
Cefoxitin—Hypotension—Doxorubicin—uterine cancer	0.00117	0.00117	CcSEcCtD
Cefoxitin—Pain—Epirubicin—uterine cancer	0.00116	0.00116	CcSEcCtD
Cefoxitin—Dyspnoea—Doxorubicin—uterine cancer	0.00112	0.00112	CcSEcCtD
Cefoxitin—Gastrointestinal pain—Epirubicin—uterine cancer	0.00111	0.00111	CcSEcCtD
Cefoxitin—Urticaria—Epirubicin—uterine cancer	0.00108	0.00108	CcSEcCtD
Cefoxitin—Pain—Doxorubicin—uterine cancer	0.00107	0.00107	CcSEcCtD
Cefoxitin—Body temperature increased—Epirubicin—uterine cancer	0.00107	0.00107	CcSEcCtD
Cefoxitin—Abdominal pain—Epirubicin—uterine cancer	0.00107	0.00107	CcSEcCtD
Cefoxitin—Gastrointestinal pain—Doxorubicin—uterine cancer	0.00103	0.00103	CcSEcCtD
Cefoxitin—Hypersensitivity—Epirubicin—uterine cancer	0.001	0.001	CcSEcCtD
Cefoxitin—Urticaria—Doxorubicin—uterine cancer	0.000998	0.000998	CcSEcCtD
Cefoxitin—Abdominal pain—Doxorubicin—uterine cancer	0.000993	0.000993	CcSEcCtD
Cefoxitin—Body temperature increased—Doxorubicin—uterine cancer	0.000993	0.000993	CcSEcCtD
Cefoxitin—Pruritus—Epirubicin—uterine cancer	0.00096	0.00096	CcSEcCtD
Cefoxitin—Diarrhoea—Epirubicin—uterine cancer	0.000929	0.000929	CcSEcCtD
Cefoxitin—Hypersensitivity—Doxorubicin—uterine cancer	0.000925	0.000925	CcSEcCtD
Cefoxitin—Pruritus—Doxorubicin—uterine cancer	0.000889	0.000889	CcSEcCtD
Cefoxitin—Vomiting—Epirubicin—uterine cancer	0.000863	0.000863	CcSEcCtD
Cefoxitin—Diarrhoea—Doxorubicin—uterine cancer	0.000859	0.000859	CcSEcCtD
Cefoxitin—Rash—Epirubicin—uterine cancer	0.000856	0.000856	CcSEcCtD
Cefoxitin—Dermatitis—Epirubicin—uterine cancer	0.000855	0.000855	CcSEcCtD
Cefoxitin—Nausea—Epirubicin—uterine cancer	0.000806	0.000806	CcSEcCtD
Cefoxitin—Vomiting—Doxorubicin—uterine cancer	0.000799	0.000799	CcSEcCtD
Cefoxitin—Rash—Doxorubicin—uterine cancer	0.000792	0.000792	CcSEcCtD
Cefoxitin—Dermatitis—Doxorubicin—uterine cancer	0.000791	0.000791	CcSEcCtD
Cefoxitin—Nausea—Doxorubicin—uterine cancer	0.000746	0.000746	CcSEcCtD
